β痕迹蛋白对冠脉介入诊疗术后造影剂肾病预测价值的相关性

苗文清; 王宇; 杨俊; 张义红; 田青; 段会仙; 赵仲文; 汪艳; 杨兴虎

β痕迹蛋白对冠脉介入诊疗术后造影剂肾病预测价值的相关性

昆明市第一人民医院心内科

基金项目:

基金：北京力生心血管健康基金会领航基金资助基目 (LHJJ20158821);

计量
- 文章访问数: 1674
- HTML全文浏览量: 610
- PDF下载量: 29
- 被引次数: 0
出版历程
- 收稿日期: 2018-03-19

Correlation study of the Predictive Value of Beta-trace Protein to Contrast-induced Nephropathy after Coronary Intervention

Funds:

基金：北京力生心血管健康基金会领航基金资助基目 (LHJJ20158821);

摘要

摘要: 目的探讨血/尿β痕迹蛋白 (βTP) 浓度预测造影剂肾病的相关性.方法收集昆明市第一人民医院收内科2016年9月至2016年12月行冠脉介入诊断和\或治疗的88例患者, 发生CIN患者为CIN组 (7例) ;未发生CIN患者为非CIN组 (81例) , 共88例.采用ELISA法测定血/尿β痕迹蛋白浓度进行用SPSS进行统计分析.结果研究结果示, CIN组及非CIN组术前、术后2 h、术后24 h血βTP水平差异有统计学意义 (P<0.05) ;CIN组及非CIN组术前、术后2 h、术后24 h尿βTP水平差异有统计学意义 (P<0.05) ;血βTP 2 h术后的ROC曲线下面积 (AUC) 为0.761, 诊断界值为567.568, 敏感度和特异度分别为71.4%和81.5%;尿βTP 2 h术后的ROC曲线下面积 (AUC) 为0.967, 诊断界值为1 428.893时, 敏感度和特异度分别为100%和97.5%.结论血/尿βTP术后2 h浓度可以作为预测造影剂肾病的新指标, 其中尿βTP敏感度及特异度优于血βTP, 且尿液样本较血液样本更容易收集.
- β痕迹蛋白 /
- 冠状动脉粥样硬化性心脏病 /
- 造影剂肾病
Abstract: Objective To investigate the correlation of the concentration of blood/urine beta-trace protein (βTP) in the prediction of contrast-induced nephropathy. Methods This study enrolled 88 patients with interventional diagnosis or treatment from september to December 2016 in the first hospital of Kunming and the patients were divided into two groups: CIN group (nn = 7) and non-CIN group (n = 81) . The concentration of blood/urine βTP was measured by ELISA method and the results was analysed with SPSS.Re s ults There was significant difference in the level of blood βTP before the operation, 2 h after operation and 24 h after the operation between the two groups (P<0.05) , so was that in the level of urine βTP (P<0.05) . The area under ROC curve (AUC) of blood βTP 2 h after the operation was 0.761, the diagnostic value was 567.568, and the sensitivity and specificity were 71.4% and 81.5% while the area of ROC curve (AUC) of urine βTP 2 h after the operation was0.967, the diagnostic value was 1428.893, and the sensitivity and specificity were 100% and 97.5%.Conclus ion The concentration of blood/urine βTP 2 h after the operation can be used as a new indicator to predict contrast-induced nephropathy. The sensitivity and specificity of urine βTP is better than those of blood βTP, and urine samples are easier to be collected than blood samples.
- Beta-trace protein /
- Coronary heart disease /
- Contrast-induced nephropathy

HTML全文

参考文献(11)

[1]	[1]SUDARSKY D, NIKOLSKY E.Contrast-induced nephropathy in interventional cardiology[J].Int J Nephrol Renovasc Dis, 2011, 4 (1) :85-99.
[2]	[2]HOFFMANN A, NIMTZ M, CONRADT H S.Molecular characterization of beta-trace protein in human serum and urine:A potential diagnostic marker for renal diseases[J].Glycobiology, 1997, 7 (4) :499-506.
[3] 中华医学会心血管病分会含碘对比剂在心血管疾病中临床应用的专家共识 (2012) [J].中华心血管病杂志, 2013, 41 (2) :94-98.
[4]陈文, 王又平, 王相智.影响造影剂肾病发病的危险因素分析[J].山东医药, 2010, 50 (41) :99-100.
[5]	[5]MAUTONE, BROWNJ R.Contrast-induced nephropathy in patients undergoing elective and urgent procedures[J].J Interv Cardiol, 2010, 23 (1) :78-85.
[6]	[6]ORENES-PINERO E, MANZANO-FERNANDEZ S;LOPEZ-CUENCA A, et al.β-Trace protein:from GFR marker to cardiovascular risk predictor[J].Clin J Am Soc Nephrol, 2013, 8 (5) :873-881.
[7]	[7]VYNCKIER L L, FLOR K M, DELANGHE S E, et al.Urinary beta-trace protein as a new renal tubular marker[J].Clin Chem, 2009, 55 (6) :1241-1243.
[8]张嘉惠, 倪兆慧.B一痕迹蛋白作为新生物标记评估肾功能及心血管风险[J].中国血液净化, 2014, 13 (7) :526-530.
[9]	[9]PO..GE U, GERHARDT T M, STOFFEL-WAGNER B, et al.Beta-Trace protein is an alternative marker for glomerular filtration rate in renal transplantation patients[J].Clin Chem, 2005, 51 (8) :1531-1533.
[10]	[10]DAJAK M, IGNJATOVIC S, STOJIMIROVIC B, et al.Urinary beta-trace protein as a tubular marker of renal dysfunction in patients with chronic kidney disease[J].Clin chim Acta, 2010, 411 (15-16) :1154-1155.
[11]	[11]ASTOR B C, SHAFI T, HOOGEVEEN R C, et al.Novel markers of Kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population[J].Am J Kidney Dis, 2012, 59 (5) :653-662.

相关文章(20)

[1]	徐文秀, 莫小凤, 杨祥民, 杨丝露, 吴凡, 李特. Logistic回归与决策树模型在碘造影剂不良反应预测中的应用, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20240911
[2]	薛佳佳, 王肖肖, 王旭, 孙源源, 朱弘璐. 甲状腺功能指标联合经颅多普勒超声及颈动脉超声在动脉粥样硬化性脑梗死血管狭窄评估中的应用, 昆明医科大学学报.
[3]	杨瑶, 刘剑雄, 张芸, 孔繁一, 刘诗翔. 大动脉粥样硬化性脑卒中与心脏功能关系的临床研究, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20221126
[4]	张文斌, 韩丹, 田扬, 赵卫. 双源CT对心脏周围脂肪组织与冠状动脉粥样硬化的相关性, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20210820
[5]	苗文清, 王宇, 杨俊, 田倪妮, 段会仙, 赵晓丽. 血Preβ1-HDL对冠心病患者冠脉病变严重程度预测价值的相关性, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20210521
[6]	熊鑫, 杨启琨, 刘凯, 瞿勇强, 雷普平, 王尚文, 李玉华. RGS17在冠状动脉粥样硬化中的表达, 昆明医科大学学报.
[7]	王宇, 苗文清, 光雪峰, 杨俊, 张义红, 田青, 段会仙, 汪艳. 血浆FKN浓度预测冠脉病变严重程度, 昆明医科大学学报.
[8]	常露. 动脉粥样硬化模型大鼠血液生化指标变化, 昆明医科大学学报.
[9]	伏忠阳. 辛伐他汀在颈动脉粥样硬化治疗中的临床效果, 昆明医科大学学报.
[10]	卢房利. β-catenin与视黄醇结合蛋白对糖尿病肾病的诊断价值, 昆明医科大学学报.
[11]	庞兴美. 彩色多普勒超声对高血压患者颈动脉粥样硬化的诊断分析, 昆明医科大学学报.
[12]	王丹. 超敏C反应蛋白、纤维蛋白原与脑梗死患者颈动脉粥样硬化的相关性分析, 昆明医科大学学报.
[13]	张涛. 彩色多普勒超声检测颈动脉粥样硬化与老年缺血性脑血管病的分析, 昆明医科大学学报.
[14]	沈志强. LOX-1与动脉粥样硬化, 昆明医科大学学报.
[15]	沈志强. LOX-1与动脉粥样硬化, 昆明医科大学学报.
[16]	陈石桂. 护理干预对造影剂过敏反应患者状态焦虑度及康复的影响, 昆明医科大学学报.
[17]	王玲. 2型糖尿病患者下肢动脉粥样硬化与骨密度改变的研究, 昆明医科大学学报.
[18]	聂志. 年轻脑梗死患者脂蛋白（a）和颈动脉粥样硬化相关性研究, 昆明医科大学学报.
[19]	. 普罗布考治疗动脉粥样硬化40例临床疗效观察, 昆明医科大学学报.
[20]	. 高血脂类风湿关节炎动脉粥样硬化患者超声分析, 昆明医科大学学报.